Redeye was hoping for a bit more in Q1, despite adverse market conditions related to macroeconomic u...
Redeye comments on BONESUPPORT’s CEO change announced yesterday.
Orders +7%, sales -1%, adj. EBITA +28% vs. our estimates Key takeaway is the continued order strengt...
Relais announced it will acquire Team Verksted Holding AS from Vy Buss AS, making it the largest ope...
Sales +29%, adj. EBITA +20%, +29% org. growth '25e-'27e EBITA estimates to increase by 1-3% Share to...
Adj. EBITA -12% vs cons, but organic growth better Est's down 3-4%, but better growth outlook mainta...
Redeye considers Arise’s Q1 2025 report to be a mixed bag, although largely in line with our estimat...
Sales 1% below cons, adj. EBITA in line with cons Consensus EBITA estimate revisions flat to slightl...
Redeye comments on Formpipe’s Q1 report showing an ACV and EBITDA – CAPEX roughly matching our expec...
Sales SEK 9.5m, EBIT SEK -14m (vs. ABGSCe 9.5m and -20m) No system deliveries in the quarter, as exp...
Redeye provides its first take on Cellavision’s Q1 report 2025, published this morning.
Redeye believes Sdiptech's Q1 report was solid despite a drop in organic sales and adjusted EBITA wh...
Redeye comments on M.O.B.A. Network’s Q1 2025 report, which came in below our expectations.
With the increased number of active centers, the complete enrolment of the European PAES study, and ...
Redeye comments on Hexatronic’s Q1 report, showing a strong development in Data Center but with Fibe...
